Breaking News
Rising Prices and Falling Values--Inflation and Social Decay
The non-Zionist Israeli Population Could Save the Day
AfD Launches 'Knife App' As Berlin Violence Surges
Oil Prices EXPLODE After Trump Signals That US Is Moving To Wartime Economy
Top Tech News
DARPA O-Circuit program wants drones that can smell danger...
Practical Smell-O-Vision could soon be coming to a VR headset near you
ICYMI - RAI introduces its new prototype "Roadrunner," a 33 lb bipedal wheeled robot.
Pulsar Fusion Ignites Plasma in Nuclear Rocket Test
Details of the NASA Moonbase Plans Include a Fifteen Ton Lunar Rover
THIS is the Biggest Thing Since CGI
BACK TO THE MOON: Crewed Lunar Mission Artemis II Confirmed for Wednesday...
The Secret Spy Tech Inside Every Credit Card
Red light therapy boosts retinal health in early macular degeneration
Hydrogen-powered business jet edges closer to certification 
New blood, computer brains and frozen heads: How billionaires 'will live forever'
Over the past year, the gap between the super-rich and the rest of us has grown wider than ever before.
But the difference between ordinary people and billionaires might be more than just money. Some high net worth individuals have been looking into extending their lives far beyond the 70 or 80 years most of us might hope for.
Peter Thiel, for example, the billionaire co-founder of PayPal, has invested in a number medical research start-ups looking extending life expectancy though his Breakout Labs fund.
One of the companies longevity obsessive Thiel has bankrolled is Ambrosia.
Ambrosia is one of three outfits looking at experimental "vampire" blood transfusions that put the blood of young people into the lens of oldies.
According to commercial finance experts ABC Finance, the cost of the trials currently ranges from £6,000 to about £215,000.